Asthma is the most common chronic disease in childhood. The pathogenesis of asthma is multifactorial and is thought to include environmental factors interacting with genetics during pregnancy and in the first years of life. In the last decades, a possible role of gut microbiota in allergic disease pathogenesis has been
demonstrated. Next generation sequencing techniques have allowed the identification of a distinct microbiome in the healthy lungs. The lung microbiome is characterized by the prevalence of bacteria belonging to the phylum Bacteroidetes (mostly Prevotella and Veilonella spp) in healthy subjects and to the phylum Proteobacteria in asthmatics (mostly Haemophilus, Moraxella, and Neisseria spp). In asthma, as well as in other diseases, the lung microbiome composition changes due to a disruption of the delicate balance between immigration and elimination of bacteria. The lung microbiome can interact with the immune system, thus influencing inflammation. Early infections with viruses, such as respiratory syncytial virus, may alter lung microbiome composition favoring the emergence of Proteobacteria, a phylum which is also linked to severity of asthma and bronchial hyperreactivity. Lastly, antibiotics may alter the gut and lung microbiota and potentially disturb the relationship between microbiota and host. Therefore, antibiotics should be prescribed with increasing awareness of their potential harmful effect on the microbiota in young children with and without asthma. The potential effects of probiotics and prebiotics on lung microbiome are unknown.
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Asthma is one of the most common chronic disease worldwide, affecting almost 300 million people with a continuously increasing prevalence. 1 It is also the main chronic disease in childhood, affecting 10% of children. A great effort is currently being focused on the search for preventive strategies, which seems feasible based on evidence suggesting that the onset of atopy and asthma may be strictly connected to several events occurring in very early stages of life. In particular, exposure to antibiotics during fetal and neonatal period, 2 being born by cesarean section, 3 formula feeding, maternal diet, and the variety of microbes one is exposed to may play a key role. 4 The mechanisms proposed by which these factors predispose to asthma are numerous, but what seems be a common feature is their effects on gut microbiota. Indeed, in the last decades many papers have been published on the role of gut dysbiosis in the pathogenesis of allergic diseases. The gut has probably been thoroughly studied because collecting samples is relatively easy compared to other bodily sites. 5 However, researchers have recently demonstrated that specific communities of bacteria are present also in the lungs and that their composition may play a crucial role in the development of asthma, as well as in the development of other respiratory diseases. Studies on the human microbiota have been complicated by a certain degree of confusion in terminology: with the term "microbiota," Authors usually refer to bacteria associated with the human body, while with "microbiome" they refer to the array of genomes of such microbes, as identified by next generation sequencing (NGS) techniques. These terms are often used interchangeably, and sometimes to include all the microorganisms associated to the human body, encompassing also viruses and fungi.
As the literature regarding the composition of lung bacterial communities' is based on NGS studies, in this work, as in the great majority of the previous studies on this subject, we will refer to the microbial communities of the lungs as "lung microbiome" (Table 1 ). 6 1.1 | Does the lung have its own microbiome?
The theory that healthy lower airways are sterile is one of the dogmas in the history of medicine: however, with the advent of NGS techniques and their application in microbiology, this hypothesis has been reconsidered due to the frequent detection of bacterial communities in healthy lower airways, as well as in other body sites formerly believed to be sterile. 7 As very few of these bacteria, if any, can be isolated in culture, this finding has two important consequences: (1) Traditional culture isolation techniques can no longer be considered the gold standard for bacteria detection and identification.
(2) Most body sites probably have their own resident microbial flora. In contrast, subjects with asthma and COPD harbored mainly Proteobacteria, including Haemophilus, Moraxella, and Neisseria spp.
In addition to showing that sick and healthy individuals have a different microbial flora, this work was the first to report that the bronchial tree of healthy subjects is colonized by bacteria. Further studies confirmed The term refers to bacterial communities associated with the human body identified by molecular methods. While this term is often used interchangeably with microbiota, sometime in a broader sense encompassing also viruses and fungi, in this review the term refers to all the genomes of bacteria found in the human body, analyzed trough the sequencing of 16S rRNA gene.
Microbiota
In the strict sense, the term refers to bacteria associated with the human body studied by traditional culture.
Virome
In the strict sense, the term refers to viruses associated with the human body.
FIGURE 1 A, Bacteria taxonomy; B, Taxonomical classification of Escherichia coli as defined the hierarchical organization showed in (A) this finding and evidenced that phylum Firmicutes (especially Veilonella spp, but also Streptococcus spp) is also highly represented in healthy individuals, 9 showing that the lung microbiome is more dynamic but less varied compared to the gut microbiome. It is now clear that lung microbiome composition depends on the resident flora of the upper airways, which, therefore, represents the main reservoir for lower airways colonization. [9] [10] Recently, Dickson et al 11 demonstrated that the oropharynx microbiome is nearly identical to the one of the right upper lung lobe, but differs from that found in the other lobes. This could be explained by the fact that, for anatomical reasons, the right upper lobe is the most susceptible to immigration of bacteria by microaspirations, which are common also in healthy subjects. [12] [13] It is therefore possible that bacteria reach the lower airways through repeated microaspirations of oropharyngeal secretions and, to a lesser extent, through diffusion from the mucosa or by direct inhalation. 9 In children, microaspirations also involve secretions from the nasopharynx, 14 that are facilitated by the peculiar anatomy of upper airways and increased production of nasal secretions during childhood. 9, 15 Any bias related to the risk of contamination by medical procedures was excluded, demonstrating that the passage of the bronchoscope through the upper airways did not significantly alter results. 11, 16 But what happens once the oropharyngeal bacteria reach the lower airways? Dickson et al 17 
| Lung microbiome and immune response
The role of the lung microbiome in pathogenesis and the natural history of respiratory diseases is incompletely understood. A growing body of evidences suggest that the lung microbiome plays an important role in the development and homeostasis of the immune response. As a consequence, it is conceivable that dysbiosis might facilitate the onset of respiratory diseases 19 and, at the same time, that the immune response affects the composition of pulmonary microbiome. 20 In other words, interactions between the host's immune system and lung microbiome may be crucial for the development of allergy and asthma, 21 as observed for the gut microbiome.
In the mouse model, for example, members of the phylum Bacteroidetes and, in particular, Prevotella spp, have been shown to reduce pulmonary inflammation, neutrophil recruitment, and proinflammatory cytokine production mediated by Toll-like receptor 2,
unlike Haemophilus influenzae, which has a proinflammatory influence. 22 Moreover, it has been demonstrated that asymptomatic human adults who exhibit lung microbiome with higher percentage of taxa characteristic of the oral cavity have increased numbers of inflammatory cells in the lower airways mucosa and higher levels of exhaled nitric oxide. 9 Furthermore, in humans, a continuous and diverse exposure to bacteria in the first years of life has been associated with reduced chances of subsequent development of asthma and atopy. 23 It is likely that such exposure occurs mainly at the airways, which represent the widest surface of the human body and Haemophilus influenzae during RSV infection. 28 Moreover, the transcriptome profiles of children with RSV infection and high levels of
Streptococcus pneumoniae and Haemophilus influenzae in the airways were characterized by an increased expression of Toll-like receptor genes as well as by activation of macrophages and neutrophils, which were in turn associated with more serious clinical manifestations. 28, 29 The evidence accrued thus far suggests that an imbalance of the respiratory microbiome favoring higher levels of the phylum While the microbiome in subjects with severe asthma is also significantly enriched in Actinobacteria, 32 in patients with severe steroid-resistant asthma Haemophilus parainfluenzae, proved to favor steroid resistance in macrophages. 33 New studies on lung microbiome are expected to shed light on many aspects of severe asthma, as well as on non-Th2-mediated asthma, which is typical of adults and is characterized by predominantly neutrophilic inflammation. 34, 35 There is no evidence so far that changes in lung microbiome are involved in asthma exacerbations, but a hypothesis to explain what happens at this level has been proposed. This is called "the dysbiosis- It will be important to analyze the impact of short-and long-term treatment with antibiotics, because antibiotics may alter the gut and lung microbiome, thus interfering with their immunomodulatory action. 36, 37 Notably, a few studies have shown some beneficial effects of macrolides on bronchial inflammation, 31 while others suggest that antibiotics may play a causal role in the development of pediatric asthma. 38 Physicians should, therefore, be aware of these potential risks and should prescribe these drugs only when necessary, especially in the case of newborns and infants. 20, 29 Even if the evidence available seems to suggest a causal role of changes in the composition of lung microbiome in asthma pathogenesis, whether such changes are primary or secondary to inflammation
has not yet been clarified sufficiently. In this respect, it will be interesting to assess whether diet or probiotics and prebiotics administration may modulate microbiome composition. Some studies have evaluated the effects of these dietary supplements on the gut microbiota and demonstrated some beneficial effects both in treating and preventing asthma. 36 Such data are not yet available for lung microbiome. 36 On a more general issue, another point to be clarified is whether the bacterial genomes detected by molecular methods in the lower airways belong to resident bacteria or are relics of past infections.
Culture isolation techniques would be the most suitable method to ascertain whether bacteria from respiratory specimens are alive or not, but the available techniques are still unable to reproduce the lung habitat enabling their growth 7 : to this aim, new culture conditions and media need to be developed soon. To advance our knowledge in the near future, data obtained from transcriptional, proteomic and metabolomic analyses will provide gene expression and metabolic data deriving only from living cells. 6 In any case, even if we were highlighting genes belonging to bacteria no longer present in the airways, this fact still helps interpret the effects of their passage in the airways. 39 Lastly, although most interest is currently directed toward the bacterial microbiome, studies on virome and mycobiome and their interactions with microbiome are also being published. 7, 29 The evidence that is emerging, along with what was already known about viruses, will possibly lead to a stronger concept of asthma as a chronic inflammatory condition triggered, exacerbated and maintained by the respiratory microbiome in a broad sense. 39 
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